BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
LEP
,
Angiogenesis
,
Arthritis
,
Adipose tissue
,
Amniocentesis
,
Tamoxifen
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tyrosine-protein kinase, Ret receptor
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Central alveolar hypoventilation syndrome
Tinea pedis
Disorder of intestine
Vesicular stomatitis Indiana virus disease
Thyroid cancer
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
4,7,10,13,16,19-docosahexaenoic acid ethyl ester
plastochromanol 8
oxalylglycine
pararosaniline
estropipate
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR192
AICDA
U2SURP
CCDC6
NR2E3
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Tyrosine-protein kinase, Ret receptor
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection…
Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Foll…
The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Dea…
A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Char…
Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICA…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ